NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Gene Therapy Week


Susan Hasty, Publisher
Table of Contents . . . August 24th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Gene Therapy Week | Other Publications

Cancer Gene Therapy - National Institutes of Health publishes research in cancer gene therapy

Cancer Gene Therapy - Reports from Winship Cancer Institute describe recent advances in cancer gene therapy

Cancer Gene Therapy - Research conducted at Hadassah University, Goldyne Savad Institute of Gene Therapy has provided new information about cancer gene therapy

Cancer Gene Therapy - Scientists at University of Helsinki, Institute for Molecular Medicine discuss research in cancer gene therapy

Cancer Gene Therapy - Studies from Osaka University, Department of Surgery reveal new findings on cancer gene therapy

Lymphoma Gene Therapy - New lymphoma gene therapy research from INSERM outlined



Return to Top of Page

-----------------------
PR Login